In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Epitope, LabOne, STC Technologies market Intercept

Executive Summary

LabOne (health care testing) and STC Technologies (diagnostic tests and medical devices) will market Epitope's (oral fluid collection products) Intercept test, which identifies TCH, cocaine, opiates, PCP, and amphetamines in oral fluid samples.
Deal Industry
  • In Vitro Diagnostics
    • Saliva-based Testing
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing
    • Co-Promotion

Related Companies

Advertisement
UsernamePublicRestriction

Register